FSD Pharma (FSDDF) Stock Price, News & Analysis

Company Overview

FSD Pharma Inc. is a clinical‐stage pharmaceutical company focused on the research, development and commercialization of cannabinoid‐based drug formulations and wellness products. Its team combines expertise in pharmaceutical R&D and cannabis science to advance novel therapeutic candidates derived from cannabidiol (CBD) and related cannabinoids.

Through Canadian subsidiaries holding production licenses under the Cannabis Act, FSD Pharma operates extract and formulation facilities that manufacture full‐spectrum CBD oils, topicals and nutraceuticals. The company also collaborates with contract research organizations and academic partners to support preclinical studies and early‐phase clinical trials targeting a range of therapeutic areas.

FSD Pharma distributes medical and wellness offerings across North America and has pursued partnerships and licensing agreements to extend its presence into Europe and other regulated markets. By integrating in‐house production capabilities with third‐party distribution networks, it aims to serve both patient and consumer segments with pharmaceutical‐grade cannabinoid solutions.

Incorporated in Canada and trading on the OTC market under the ticker FSDDF, FSD Pharma is guided by a management team with backgrounds in pharmaceutical development, regulatory affairs and cannabis cultivation. The company continues to build its pipeline through strategic alliances, positioning itself within the emerging global cannabinoid therapeutics sector.

Key Stats

• Today's Range: $3.24 to $4.08
• 50-Day Range: $2.84 to $5.25
• 52-Week Range: $3.43 to $68.66
• Volume: 1.83 million shs
• Average Volume: 11,100 shs
• Market Capitalization: $26.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:FSDDF
• Previous Symbol: OTCMKTS:FSDDF
• CIK: N/A
• Web: fsdpharma.com
• Phone: (416) 854-8884
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.81
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $70 thousand
• Price / Sales: 374.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,580,000
• Free Float: N/A
• Market Cap: $26.23 million
• Optionable: Not Optionable
• Beta: N/A